PUBLISHER: 360iResearch | PRODUCT CODE: 1606850
PUBLISHER: 360iResearch | PRODUCT CODE: 1606850
Enflurane Market by Route of Administration (Inhalation, Oral), End-Use (Ambulatory Surgical Centers, Hospitals) - Global Forecast 2025-2030
The Enflurane Market was valued at USD 206.39 million in 2023, expected to reach USD 215.70 million in 2024, and is projected to grow at a CAGR of 4.59%, to USD 282.70 million by 2030.
Enflurane, an inhalational anesthetic agent used primarily during surgical procedures, presents a dynamic market profile influenced by several medical and technological advancements. The scope of its application is broad, but its use has been somewhat restricted due to the emergence of newer anesthetics with superior safety profiles. Despite these limitations, enflurane finds relevance in settings where cost considerations and specific anesthetic requirements align. It is essential for its low cost and potency, and serves critical roles in operating rooms where rapid onset and recovery are necessary. The market insights reveal key growth drivers including the rising number of surgeries globally, especially in emerging economies where budget constraints prompt consideration of less expensive anesthetic options. Opportunities lie prominently in expanding healthcare infrastructure and increasing surgical volumes which can boost the enflurane market demand. However, the market grapples with limitations such as heightened competition from newer agents like sevoflurane and desflurane, concerns regarding environmental impact, and potential adverse effects, which pose challenges to its widespread adoption. Despite these, innovations in delivery mechanisms and improved formulations could mitigate some of these challenges, offering potential areas for research. Enhanced vaporizer technologies and precision delivery systems could reduce dosage requirements and side effects, balancing efficacy and safety. Further, ongoing research into minimizing environmental impact through proper waste management practices provides additional pathways for market expansion. Thus, while enflurane's market is somewhat static in mature regions, strategic investments in emerging markets and the development of greener practices present substantial avenues for growth. As the market's nature is competitive yet niche, it is vital for businesses to emphasize targeted developments and to strategically navigate regulatory landscapes to optimize growth potential.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 206.39 million |
| Estimated Year [2024] | USD 215.70 million |
| Forecast Year [2030] | USD 282.70 million |
| CAGR (%) | 4.59% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enflurane Market
The Enflurane Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Rising incidences of chronic diseases and accidents globally
- Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
- Market Restraints
- Emergence of newer and advanced anesthetic agents
- Market Opportunities
- Technological innovations in anesthesia delivery and monitoring techniques
- Ongoing research into biodegradable, eco-friendly alternatives
- Market Challenges
- Regulatory scrutiny and stringent guidelines governing the use of enflurane
Porter's Five Forces: A Strategic Tool for Navigating the Enflurane Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enflurane Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Enflurane Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enflurane Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Enflurane Market
A detailed market share analysis in the Enflurane Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enflurane Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enflurane Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Enflurane Market
A strategic analysis of the Enflurane Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Enflurane Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Baxter International, Inc., Boehringer Ingelheim International GmbH, Dragerwerk AG & Co. KGaA, GE HealthCare Technologies Inc., Hikma Pharmaceuticals PLC, J&TEC CO., LTD., and Sanofi S.A..
Market Segmentation & Coverage
This research report categorizes the Enflurane Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Route of Administration, market is studied across Inhalation and Oral.
- Based on End-Use, market is studied across Ambulatory Surgical Centers and Hospitals.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising incidences of chronic diseases and accidents globally
- 5.1.1.2. Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
- 5.1.2. Restraints
- 5.1.2.1. Emergence of newer and advanced anesthetic agents
- 5.1.3. Opportunities
- 5.1.3.1. Technological innovations in anesthesia delivery and monitoring techniques
- 5.1.3.2. Ongoing research into biodegradable, eco-friendly alternatives
- 5.1.4. Challenges
- 5.1.4.1. Regulatory scrutiny and stringent guidelines governing the use of enflurane
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Route of Administration: Increasing administration of enflurane via inhalation
- 5.2.2. End-Use: Evolving usage of enflurane by hospitals
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Enflurane Market, by Route of Administration
- 6.1. Introduction
- 6.2. Inhalation
- 6.3. Oral
7. Enflurane Market, by End-Use
- 7.1. Introduction
- 7.2. Ambulatory Surgical Centers
- 7.3. Hospitals
8. Americas Enflurane Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Enflurane Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
10. Europe, Middle East & Africa Enflurane Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
11. Competitive Landscape
- 11.1. Market Share Analysis, 2023
- 11.2. FPNV Positioning Matrix, 2023
- 11.3. Competitive Scenario Analysis
- 11.3.1. SunMed Completes Acquisition Of Respiratory & Anesthesia Consumables Business Of Vyaire Medical
- 11.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. AbbVie Inc.
- 2. Baxter International, Inc.
- 3. Boehringer Ingelheim International GmbH
- 4. Dragerwerk AG & Co. KGaA
- 5. GE HealthCare Technologies Inc.
- 6. Hikma Pharmaceuticals PLC
- 7. J&TEC CO., LTD.
- 8. Sanofi S.A.
LIST OF FIGURES
- FIGURE 1. ENFLURANE MARKET RESEARCH PROCESS
- FIGURE 2. ENFLURANE MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 11. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 13. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 15. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 19. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. ENFLURANE MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. ENFLURANE MARKET DYNAMICS
- TABLE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 14. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 15. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 16. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 17. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 18. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 19. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 20. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 21. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 22. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 23. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 24. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 25. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 26. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 27. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 28. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 29. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 30. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 31. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 32. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 33. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 34. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 35. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 36. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 37. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 38. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 39. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 40. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 41. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 42. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 43. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 44. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 45. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 46. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 47. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 48. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 49. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 50. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 51. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 52. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 53. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 54. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 55. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 56. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 57. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 58. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 59. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 60. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 61. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 62. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 63. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 64. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 65. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 66. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 67. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 68. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 69. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 70. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 71. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 72. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 73. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 74. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 75. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 76. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 77. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 78. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 79. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 80. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 81. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 82. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 83. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 84. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 85. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 86. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 87. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 88. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 89. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 90. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 91. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 92. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 93. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 94. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 95. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 96. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 97. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 98. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
- TABLE 99. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 100. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023
